Nitisinone Treatment Affects Biomarkers of Bone and Cartilage Remodelling in Alkaptonuria Patients

Nitisinone has been approved for treatment of alkaptonuria (AKU). Non-invasive biomarkers of joint tissue remodelling could aid in understanding the molecular changes in AKU pathogenesis and how these can be affected by treatment. Serological and urinary biomarkers of type I collagen and II collagen...

Descripción completa

Detalles Bibliográficos
Autores principales: Genovese, Federica, Frederiksen, Peder, Bay-Jensen, Anne-Christine, Karsdal, Morten A., Milan, Anna M., Olsson, Birgitta, Rudebeck, Mattias, Gallagher, James A., Ranganath, Lakshminarayan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341572/
https://www.ncbi.nlm.nih.gov/pubmed/37446173
http://dx.doi.org/10.3390/ijms241310996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341572/
https://www.ncbi.nlm.nih.gov/pubmed/37446173
http://dx.doi.org/10.3390/ijms241310996

Ejemplares similares